Determination of Zolmitriptan in Human Plasma by HPLC-MS and Study on Bioequivalence of Domestic and Import Zolmitriptan Tablets

DING Jin-song,ZHU Rong-hua,ZHU Yun-gui,LI Huan-de

DOI: https://doi.org/10.3321/j.issn:1001-2494.2006.19.016

2006-01-01

Abstract:OBJECTIVE To develop a HPLC-MS method for the determination of zolmitriptan in plasma and evaluate the bioequivalence of domestic and imported zolmitriptan tablets.METHODS Samples were pre-treated by solid extraction and analyzed by a Nucleodur C_ 18 column. The mobile phase consisted of CH_ 3 CN-CHCOOH(0.05%) = 10∶90, and the internal standard was sumatriptan. A single oral dose of 5 mg domestic and imported zolmitriptan was administered to 18 healthy volunteers in a randomized crossover study. Zolmitriptan concentration in plasma was determined by the developed LC-MS method, and the pharmacokinetics and bioavailability were studied. RESULTS The calibration curve was linear over the range of 0.25～40 μg·L~ -1 (r=0.999 5), the solid extraction recoveries of zolmitriptan and sumatriptan respectively were between 86.7%～96.4%(n=5)and 79.7%～81.4%(n=15), the method recovery was in the range of 102.2%～106.0% (n=5) , inter-day and intra-day RSDs were 2.3%～3.4%(n=5) and 3.4%～5.4%(n=5),respectively. The AUC_ 0～t of the two tablets were(59.6±24.4) and (56.6±31.2) μg·h·L~ -1 ,AUC_ 0～∞ were (62.3±25.9) and (60.2±24.0) μg·h·L~ -1 ,ρ_ max were(12.4±4.2) and(12.7±4.4) μg·L~ -1 ,t_ max were (1.9±0.5) and (2.1±0.4) h, the relative bioavailability of domestic to imported tablet was (107.1±25.7)%. CONCLUSION Statistice analysis shows no significant differences between the two preparations, and bioequivalence is observed. The established HPLC-MS method is accuracy and sensible for zolmitriptan determination.